P/F Bakkafrost BAKKA
Oslo Børs · Consumer Defensive · Farm Products
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for P/F Bakkafrost
| DKK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 7,130 | 7,141 | 7,334 | 7,007 |
| EBITDA | 2,290 | 1,967 | 1,755 | 1,582 |
| Net income | 1,345 | 956 | 657 | 530 |
| Balance sheet | ||||
| Equity | 10,392 | 10,863 | 11,165 | 11,042 |
| Total debt | 3,843 | 4,341 | 3,779 | 5,044 |
| Cash | 720 | 412 | 481 | 300 |
| Net debt | 3,123 | 3,930 | 3,299 | 4,744 |
| Ratios and per share | ||||
| EBITDA margin | 32.1% | 27.6% | 23.9% | 22.6% |
| Profit margin | 18.9% | 13.4% | 9.0% | 7.6% |
| Return on equity | 12.9% | 8.8% | 5.9% | 4.8% |
| Earnings/share (DKK) | 22.76 | 16.14 | 11.08 | 8.94 |
| Book value/share (DKK) | 175.85 | 183.46 | 188.38 | 186.23 |
| Shares outstanding (M) | 59 | 59 | 59 | 59 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Quarterly figures from the reports
BetaFrom the company's own reports: 47 reports read by AI, every figure checked against the report's page and arithmetic.
Source: the Q3 2026 and First Nine Months of 2026 report, page 16, published 2026-11-02.
| Quarter | Revenue | Operating profit | Profit | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 2026 | 1,681 | 323 | 190 | 3.21 | … | Q3 2026 and First Nine Months of 2026, p. 16 |
| Q2 2026 | 1,826 | −192 | −161 | −2.71 | … | Q2 2026 and H1 2026, p. 16 |
| Q1 2026 | 2,114 | 470 | 306 | 5.17 | … | Q1 2026, p. 16 |
| Q4 2025 | 1,847 | 828 | 583 | 9.97 | … | Q4 2025 and the year 2025, p. 16 |
| Q3 2025 | 1,686 | 131 | 76 | 1.29 | … | Q3 2026 and First Nine Months of 2026, p. 16 |
| Q2 2025 | 1,575 | −133 | −136 | −2.33 | … | Q2 2026 and H1 2026, p. 16 |
| Q1 2025 | 1,899 | 52 | −6 | −0.10 | … | Q1 2025, p. 16 |
| Q4 2024 | 1,470 | 667 | 481 | 8.04 | … | Q4 2024 and the year 2024, p. 16 |
| Q3 2024 | 1,737 | −102 | −114 | −1.96 | … | Q3 2024 and First Nine Months of 2024, p. 16 |
| Q2 2024 | – | – | −116 | – | … | Q2 2025 and H1 2025, p. 16 |
| Q1 2024 | 2,206 | 528 | 401 | 6.77 | … | Q1 2025, p. 16 |
| Q4 2023 | 1,562 | 550 | 394 | 6.62 | … | Q4 2023 and the year 2023, p. 15 |
Amounts in DKK million, EPS in DKK. Each quarter as first reported, as a backtest would have seen it. Adjusted EPS (without one-off items) is shown once the one-off items have been checked against the companies' own adjusted figures.
One-off items in the reports
- 2026-09-30 Income from associates, excluded from operational EBIT: +5.7 DKK million (Q3 2026 and First Nine Months of 2026, p. 16)
- 2026-09-30 Fair value adjustment of biological assets, excluded from operational EBIT: +230.7 DKK million (Q3 2026 and First Nine Months of 2026, p. 16)
- 2026-09-30 Revenue tax, excluded from operational EBIT: −41.2 DKK million (Q3 2026 and First Nine Months of 2026, p. 16)
- 2026-06-30 Income from associates, excluded from operational EBIT: −1.0 DKK million (Q2 2026 and H1 2026, p. 16)
- 2026-06-30 Revenue tax, excluded from operational EBIT: −57.5 DKK million (Q2 2026 and H1 2026, p. 25)
- 2026-06-30 Fair value adjustment of biological assets, excluded from operational EBIT and adjusted EPS: −406.3 DKK million (Q2 2026 and H1 2026, p. 16)
- 2026-03-31 Write-off of older delousing equipment made obsolete by the dual-freshwater treatment vessel Bakkafossur (Services segment): −18.0 DKK million (Q1 2026, p. 6)
- 2026-03-31 Income from associates, excluded from operational EBIT: +3.5 DKK million (Q1 2026, p. 16)
Found by AI and still being validated: hover for the report's own words.
Sign in for free to open each report on the page a figure comes from.
Extracted by an AI model from the reports and can be wrong. Not investment advice.
Key figures
| P/E | 34.4 |
| P/B | 1.7 |
| EV / EBITDA | 14.5 |
| Net debt / EBITDA | 3.0 |
| Return on equity | 4.8% |
| Profit margin | 7.6% |
| Beta 1Y | 0.56 |
| Revenue growth 1Y | −4.5% |
| Revenue CAGR 3Y | −0.6% |
| Earnings/share CAGR 3Y | −26.8% |
| ROE avg. 3Y | 6.5% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2026 | 5.06 |
| 2025 | 13.37 |
| 2024 | 13.69 |
| 2023 | 15.63 |
| 2022 | 6.70 |
Not investment advice. Figures may contain errors from the data source.